Location: New York, NY
CIK: 0001609251 · Show all filings
Period: Q1 2023 (← Previous) (Next →)
Filing Date: May 16, 2023
Total Value: $329M
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BIIB | BIOGEN INC | 177,126 | $49.25M | 15.0% | $267.94 | +3.3% | — | 09062X103 |
| REGN | REGENERON PHARMACEUTICALS | 59,488 | $48.88M | 14.8% | $342.96 | +118.7% | — | 75886F107 |
| UTHR | UNITED THERAPEUTICS CORP | 202,110 | $45.27M | 13.7% | $127.97 | +92.6% | — | 91307C102 |
| EXEL | EXELIXIS INC | 2,135,868 | $41.46M | 12.6% | $18.49 | -5.8% | — | 30161Q104 |
| ALKS | ALKERMES PLC | 1,395,797 | $39.35M | 11.9% | $18.73 | +45.4% | — | G01767105 |
| EMBC | EMBECTA CORP | 1,062,123 | $29.87M | 9.1% | $25.42 | -0.3% | — | 29082K105 |
| CAH | CARDINAL HEALTH INC | 353,278 | $26.67M | 8.1% | $56.53 | +26.5% | — | 14149Y108 |
| ENTA | ENANTA PHARMACEUTICALS INC | 603,301 | $24.4M | 7.4% | $45.86 | +4.1% | — | 29251M106 |
| — | TARO PHARMACEUTICAL INDUS | 641,910 | $15.61M | 4.7% | $70.84 | — | — | M8737E108 |
| EGRX | EAGLE PHARMACEUTICALS INC | 113,737 | $3.227M | 1.0% | $44.36 | -33.1% | — | 269796108 |
| KOD | KODIAK SCIENCES INC | 459,489 | $2.849M | 0.9% | $33.04 | -78.8% | — | 50015M109 |
| VNDA | VANDA PHARMACEUTICALS INC | 361,560 | $2.455M | 0.7% | $10.33 | -31.9% | — | 921659108 |